We are here to extend our lives by THINKING DIFFERENT

Saturday, June 13, 2009

Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo in Estonia

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo
This study is currently recruiting participants.
Verified by Novartis, June 2009
First Received: June 4, 2009 Last Updated: June 10, 2009 History of Changes
Sponsored by: Novartis Pharmaceuticals
Information provided by: Novartis
ClinicalTrials.gov Identifier: NCT00918957

Estonia



http://www.clinicaltrials.gov/ct2/show/NCT00918957?term=cystic+fibrosis&recr=Open

No comments:

Post a Comment